• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance.

作者信息

Zhang X-Y, Jia R-R, Xiang X, Gong W-F, Xiang B-D, Zhong J-H, Li L-Q

机构信息

Research Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

出版信息

Aliment Pharmacol Ther. 2017 Nov;46(9):906-908. doi: 10.1111/apt.14272.

DOI:10.1111/apt.14272
PMID:29023877
Abstract
摘要

相似文献

1
Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance.
Aliment Pharmacol Ther. 2017 Nov;46(9):906-908. doi: 10.1111/apt.14272.
2
Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.
Aliment Pharmacol Ther. 2017 May;45(9):1286-1288. doi: 10.1111/apt.13983.
3
HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.中国慢性乙型肝炎患者的HBsAg血清学清除：病毒学、组织学及临床方面
Hepatology. 2004 Jun;39(6):1694-701. doi: 10.1002/hep.20240.
4
Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance - authors' reply.
Aliment Pharmacol Ther. 2017 May;45(9):1288-1289. doi: 10.1111/apt.14026.
5
Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma.
Aliment Pharmacol Ther. 2016 Jul;44(2):210-1. doi: 10.1111/apt.13674.
6
Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors' reply.信函：乙肝表面血清学清除确实降低肝细胞癌风险——作者回复
Aliment Pharmacol Ther. 2016 Sep;44(6):650-1. doi: 10.1111/apt.13730.
7
Spontaneous Seroclearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma.乙肝表面抗原自发清除与肝细胞癌风险。
Clin Gastroenterol Hepatol. 2019 May;17(6):1204-1206. doi: 10.1016/j.cgh.2018.08.019. Epub 2018 Aug 13.
8
Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.慢性乙型肝炎患者乙肝表面抗原血清学清除后的长期预后
Am J Med. 2006 Jan;119(1):71.e9-16. doi: 10.1016/j.amjmed.2005.02.033.
9
A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations.
J Hepatol. 2022 Dec;77(6):1722-1724. doi: 10.1016/j.jhep.2022.05.032. Epub 2022 Jun 9.
10
Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.慢性乙型肝炎感染患者的乙肝表面抗原血清学清除：一项临床研究。
J Int Med Res. 2013 Oct;41(5):1732-9. doi: 10.1177/0300060513487643. Epub 2013 Aug 1.